U.S. coffee giant Starbucks (NASDAQ:SBUX) has dismissed rumors suggesting it is planning a full exit from its China operations. The company issued a statement clarifying that it is not currently considering selling its China business, countering a report published by Chinese financial outlet Caixin.
The Caixin report, which cited unnamed sources, claimed that Starbucks had engaged in early-stage talks with more than a dozen potential buyers regarding parts of its China operations. However, it did not specify which assets were under discussion or provide details on the nature of the talks. The report also lacked clarity on whether the discussions involved a full or partial sale.
China remains a key growth market for Starbucks, with the company continuing to expand aggressively despite rising competition from domestic rivals like Luckin Coffee. As of early 2025, Starbucks operated more than 6,800 stores in China and had previously expressed long-term confidence in its presence there.
In response to the speculation, Starbucks emphasized its commitment to the Chinese market and reiterated its strategic plans for continued growth in the region. The company has consistently highlighted China as its second-largest market after the U.S., contributing significantly to global revenue.
The clarification aims to calm investor concerns sparked by the Caixin report and reaffirm Starbucks’ focus on international expansion. Shares of Starbucks saw modest fluctuations following the news but remained largely stable as of Tuesday morning.
With China’s coffee market projected to grow rapidly in the coming years, Starbucks’ ongoing investment and denial of exit rumors underscore its competitive stance and long-term ambitions in the region. The company continues to invest in digital innovation, store openings, and localization to maintain its stronghold in the world’s most populous nation.


SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Apple Turns 50: From Garage Startup to AI Crossroads
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 



